Adam C Mues1, Jaime Landman. 1. Department of Urology, Columbia University, 161 Fort Washington Avenue, 11th Floor, New York, NY 10032, USA. adammues@gmail.com
Abstract
INTRODUCTION: Changes in the management of minimally invasive oncologic renal surgery have introduced ablative therapies as the most recent advancement in minimally invasive technology. METHODS: The current evidence-based medicine on the topic of laparoscopic (LCA) and percutaneous (PCA) renal cryoablation was gathered and outlined in this review. The mechanism and surgical approach to performing renal cryoablation as well a focus on the oncologic and renal functional outcomes after cryoablation will be discussed. RESULTS: Although initially recommended only for patients who were at a high surgical risk, presence of a solitary kidney, or in elderly patients, renal cryoablation, has expanded to include the majority of patients being treated for a small (<3.5 cm) renal cortical neoplasm. CONCLUSION: Renal cryoablation has become a viable minimally invasive treatment option for the majority patients diagnosed with a small (≤ 3cm) renal cortical neoplasm. Cryoablation does not seem to impact post-ablative renal function regardless of surgical approach, pre-ablation renal function, or presence of a solitary kidney.
INTRODUCTION: Changes in the management of minimally invasive oncologic renal surgery have introduced ablative therapies as the most recent advancement in minimally invasive technology. METHODS: The current evidence-based medicine on the topic of laparoscopic (LCA) and percutaneous (PCA) renal cryoablation was gathered and outlined in this review. The mechanism and surgical approach to performing renal cryoablation as well a focus on the oncologic and renal functional outcomes after cryoablation will be discussed. RESULTS: Although initially recommended only for patients who were at a high surgical risk, presence of a solitary kidney, or in elderly patients, renal cryoablation, has expanded to include the majority of patients being treated for a small (<3.5 cm) renal cortical neoplasm. CONCLUSION: Renal cryoablation has become a viable minimally invasive treatment option for the majority patients diagnosed with a small (≤ 3cm) renal cortical neoplasm. Cryoablation does not seem to impact post-ablative renal function regardless of surgical approach, pre-ablation renal function, or presence of a solitary kidney.
Authors: John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck Journal: J Natl Cancer Inst Date: 2006-09-20 Impact factor: 13.506
Authors: Kyle J Weld; Robert S Figenshau; Ramakrishna Venkatesh; Sam B Bhayani; Caroline D Ames; Ralph V Clayman; Jaime Landman Journal: Urology Date: 2007-03 Impact factor: 2.649
Authors: Igor Frank; Michael L Blute; Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke Journal: J Urol Date: 2005-06 Impact factor: 7.450
Authors: John B Malcolm; Joshua E Logan; Robert W Given; Raymond Lance; Harlan Vingan; Sarah C Shaves; Michael Fabrizio Journal: J Endourol Date: 2010-03 Impact factor: 2.942
Authors: D Brooke Johnson; Stephen B Solomon; Li-Ming Su; Edward D Matsumoto; Louis R Kavoussi; Stephen Y Nakada; Timothy D Moon; W Bruce Shingleton; Jeffrey A Cadeddu Journal: J Urol Date: 2004-09 Impact factor: 7.450
Authors: Khalid Badwan; Keegan Maxwell; Ramakrishna Venkatesh; Robert S Figenshau; Dan Brown; Cathy Chen; Sam B Bhayani Journal: J Endourol Date: 2008-06 Impact factor: 2.942